Last reviewed · How we verify
NCT05293652
Effect of Hydrocortisone Iontophoresis Versus Hydrocortisone Phonophoresis On Post Surgical Scar
NA trial testing Iontophoresis in Scar in 60 participants. Completed in 15 February 2022.
15 January 2022
Quick facts
| Lead sponsor | Horus University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 September 2021 |
| Primary completion | 15 January 2022 |
| Estimated completion | 15 February 2022 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Iontophoresis
- Phonophoresis
- traditional PT program
Conditions studied
- Scar — all drugs for Scar →
- Hydrocortisone — all drugs for Hydrocortisone →
- Iontophoresis — all drugs for Iontophoresis →
- Phonophoresis — all drugs for Phonophoresis →
Sponsor
Horus University
Who can join
Adults 20 to 35, any sex, with Scar or Hydrocortisone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study will be to compare the effect of hydrocortisone iontophoresis and hydrocortisone phonophoresis on the treatment of surgical scar and overall scar appearance.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05293652
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Iontophoresis
Trials testing the same drug.
- NCT07395895 — Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women · Phase 3 · not yet recruiting
- NCT07043699 — Effect of Phonophoresis Versus Iontophoresis in the Treatment of Perimenopausal Plantar Fasciitis · NA · completed
- NCT04660162 — Comparison of Laser Speckle Contrast Imaging and Laser Doppler Imaging · NA · completed
- NCT03606980 — Iontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in Pediatrics · Phase 2 · terminated
- NCT04671030 — Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI · Phase 1 · completed
Other recruiting trials for Scar
Currently open trials in the same condition.
- NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
- NCT06533072 — Infrared LED Lighting Application and Wound Healing · NA · recruiting
- NCT06386549 — Effect of a Tele-rehabilitation Programme in Children With Burns: a Randomized Controlled Trial · NA · recruiting
- NCT05408117 — Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color · NA · recruiting
- NCT05501327 — Dose Regimen Study of SLI-F06 in Healthy Volunteers · Phase 2 · recruiting
Other Horus University trials
Trials by the same sponsor.
- NCT06457373 — Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation · NA · not yet recruiting
- NCT07075276 — Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement · NA · recruiting
- NCT07078058 — Low Level Laser VS Transcutaneous Vagus Nerve Stimulation on Vascular Changes in Patients With Diabetic Polyneuropathy · NA · not yet recruiting
- NCT06456944 — Effect of Selected Rehabilitation Program in Patients With Plantar Fasciitis · NA · completed
- NCT06578663 — Electrical Dry Needling Versus Iontophoresis in Treating Chronic Unilateral Knee Osteoarthritis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05293652 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Horus University
- Last refreshed: 24 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05293652.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing